Drug hope for cystic fibrosis sufferers
Cystic fibrosis patients have welcomed news today of a major breakthrough in the treatment of the disease.
An international research team, led by scientists at Queen's University, Belfast, revealed results of trials of a new drug which appears to have a major effect on treating the lung disease.
The drug, VX-770, provides a significant improvement in lung function, reduces disease flare-ups and improves the overall quality of life of patients.
A licence for the new medication will be sought in the autumn.
The Belfast research team said the drug would benefit sufferers with the so-called 'Celtic gene', a genetic mutation particularly common in Ireland.
Delighted researchers said VX-770 is the first drug to target the basic defect caused by the gene mutation in patients.
The drug is expected to be available next year.